Page 3 - ராபர்ட் ஜாஃப் இணை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ராபர்ட் ஜாஃப் இணை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ராபர்ட் ஜாஃப் இணை Today - Breaking & Trending Today

Lannett Announces Offering Of $350 Million Senior Secured Notes Due 2026

Lannett Announces Offering Of $350 Million Senior Secured Notes Due 2026
News provided by
Share this article
Share this article
PHILADELPHIA, April 6, 2021 /PRNewswire/ Lannett Company, Inc. (NYSE: LCI) (the Company ) today announced that it intends to offer, subject to market conditions and other factors, $350 million aggregate principal amount of senior secured notes due 2026 (the Notes ) in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the Securities Act ) and outside the United States to persons other than U.S. persons in reliance upon Regulation S under the Securities Act.
The Notes are expected to bear interest that will be payable semiannually. The Notes will mature in April 2026, unless earlier redeemed or repurchased in accordance with their terms. The Notes will be secured by first priority liens on substantially all of the assets of the Company and the guarantors, othe ....

United States , Robert Jaffe , Exchange Commission , Company Form , Lannett Company , Lannett Company Inc , Robert Jaffe Co , Securities Act , ஒன்றுபட்டது மாநிலங்களில் , ராபர்ட் ஜாஃப் , பரிமாற்றம் தரகு , நிறுவனம் வடிவம் , லானெட் நிறுவனம் , லானெட் நிறுவனம் இன்க் , ராபர்ட் ஜாஃப் இணை , பத்திரங்கள் நாடகம் ,

Lannett Development Of Biosimilar Insulin Glargine Product Continues To Advance

Lannett Development Of Biosimilar Insulin Glargine Product Continues To Advance
FDA Provides Feedback on Pivotal Trial Protocol and Statistical Analysis Plan
News provided by
Share this article
Share this article
PHILADELPHIA, March 10, 2021 /PRNewswire/ Lannett Company, Inc. (NYSE: LCI) today announced that it recently received feedback from the U.S. Food and Drug Administration (FDA) regarding biosimilar insulin glargine, a product the company is co-developing with its strategic alliance partners within the HEC Group of companies (HEC). Lannett sought and received comments from the FDA related to the pivotal trial protocol and statistical analysis plan (SAP) for the development program. ....

United States , Robert Jaffe , Exchange Commission , Lannett Company , A Biosimilar Biological Product Development , Lannett Company Inc , Drug Administration , Robert Jaffe Co , Biosimilar Biological Product Development , Investigational New Drug Application , ஒன்றுபட்டது மாநிலங்களில் , ராபர்ட் ஜாஃப் , பரிமாற்றம் தரகு , லானெட் நிறுவனம் , லானெட் நிறுவனம் இன்க் , ராபர்ட் ஜாஃப் இணை ,

Lannett To Report Fiscal 2021 Second-Quarter Financial Results, Host Conference Call On Wednesday, February 3

Share this article
Share this article
PHILADELPHIA, Jan. 27, 2021 /PRNewswire/ Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its fiscal 2021 second quarter on Wednesday, February 3, 2021, after the market closes. Lannett management will host a conference call that same afternoon at 4:30 p.m. Eastern Time to review the company s performance and answer questions.
The conference call will be available to interested parties by dialing 800-447-0521 from the U.S. or Canada, or 847-413-3238 from international locations, passcode 50088413. The call will be broadcast via the Internet at www.Lannett.com. Listeners are encouraged to visit the website at least 10 minutes prior to the start of the scheduled presentation to register, download and install any necessary audio software. A playback of the call will be archived and accessible on the same website for at least three months. ....

United States , Robert Jaffe , Lannett Company , Lannett Company Inc , Robert Jaffe Co , ஒன்றுபட்டது மாநிலங்களில் , ராபர்ட் ஜாஃப் , லானெட் நிறுவனம் , லானெட் நிறுவனம் இன்க் , ராபர்ட் ஜாஃப் இணை ,